Others have disagreed with me, but I do not think that smoking cessation hold and subsequent release were good news. Of course the resumption was good news, but the trial was effectively set back several months.
There was also more to it than alignment with dosage.
I'm unsure whether this is a significant detail: but the eligibility criteria for the study were tightened. This could have been because the study needed to relaunch anyway and they took the opportunity .I
The trial that I was talking My post about that I expect the results from soon about was the asthma trial funded by NIH.
After much research, I believe, and you can do your own due diligence, that: Overall this company is substantially undervalued.
Apologies for errors in this message as I have dictated it
IVX Price at posting:
7.9¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)